The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer

NCT05710809 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-04-06

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the cause of dizziness and decline in walking ability in in older adults ≥65 years during chemotherapy treatment for colorectal cancer. Another goal is to investigate if a comprehensive geriatric assessment and three months' specialized physical group-based exercise three times/week can counteract muscle weakness, vertigo, instability, impaired walking balance, and neuropathy

Conditions

  • Colorectal Cancer
  • Oncologic Complications
  • Comprehensive Geriatric Assessment
  • Vestibular Rehabilitation
  • Geriatric Oncology
  • Sarcopenia
  • Vertigo
  • Cancer
  • Rehabilitation
  • Exercise
  • Geriatric
  • Elderly
  • Frail
  • Older Adults
  • Chemotherapy
  • Chemotherapy-induced Peripheral Neuropathy
  • Resistance Training
  • Balance Training
  • Postural Stability
  • Pragmatic Trial
  • Personal Medicine
  • Individualised

Interventions

OTHER

Targeted specialized physical group-based exercise and Comprehensive Geriatric Assessement

Vestibular rehabilitation, balance- and progressive resistance training for three months' three times/week and Comprehensive Geriatric Assessement including corresponding interventions

Sponsors & Collaborators

  • Copenhagen University Hospital - Rigshospitalet, Department of Occupational Therapy and Physiotherapy

    collaborator UNKNOWN
  • Copenhagen University Hospital at Herlev

    collaborator OTHER
  • Copenhagen University Hospital - Bispebjerg and Frederiksberg Hospital

    collaborator UNKNOWN
  • Odense University Hospital, Department of Geriatric Medicine

    collaborator UNKNOWN
  • Copenhagen University Hospital - Amager and Hvidovre Hospital

    collaborator UNKNOWN
  • Rigshospitalet, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2027-05-01
Completion
2027-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05710809 on ClinicalTrials.gov